المؤلفون: Ana Arance, Marta Nyakas, Nageatte Ibrahim, Igor Puzanov, Antoni Ribas, Reinhard Dummer, Jianxin Lin, Robin Mogg, Caroline Robert, Dirk Schadendorf, Ahmad A. Tarhini, Kim Margolin, Blanca Homet Moreno, Omid Hamid, Jacob Schachter, Matteo S. Carlino, Jose Lutzky, Paolo A. Ascierto, Steven J. O'Day, Adil Daud, Georgina V. Long

المصدر: JAMA Oncol

مصطلحات موضوعية: Oncology, Male, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Medizin, Subgroup analysis, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Double-Blind Method, Internal medicine, Medicine, Humans, 030212 general & internal medicine, neoplasms, Melanoma, Protein Kinase Inhibitors, Survival analysis, Original Investigation, Aged, Mitogen-Activated Protein Kinase Kinases, business.industry, MEK inhibitor, Middle Aged, medicine.disease, Survival Analysis, Clinical trial, Treatment Outcome, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Mutation, Population study, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a942c45d9a0d560a1e0582292a5fe85Test
https://europepmc.org/articles/PMC7366279Test/

المؤلفون: Catriona M. McNeil, Christian U. Blank, Antoni Ribas, Jean-Jacques Grob, Matteo S. Carlino, Omid Hamid, Clemens Krepler, Michal Lotem, James Larkin, Caroline Robert, Teresa M. Petrella, Paul Lorigan, Laurent Mortier, Georgina V. Long, Erin Jensen, Jacob Schachter, Scott J. Diede, Bart Neyns, Ana Arance, Adil Daud

المساهمون: Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, Laboratory of Molecullar and Cellular Therapy

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Long term survival, medicine, In patient, business, 030215 immunology, medicine.drug, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b58ea7696aac607a6b8b94623bd747Test
https://biblio.vub.ac.be/vubir/longterm-survival-fromTest-pembrolizumab-pembro-completion-and-pembro-retreatment-phase-iii-keynote006-in-advanced-melanoma(06384d96-ea38-49d1-a40c-297993de00d7).html

المؤلفون: Jin Zhang, Jeffrey S. Weber, James R. Anderson, Anthony M. Joshua, Adil Daud, Scot Ebbinghaus, Richard F. Kefford, Richard W. Joseph, Amita Patnaik, Peter Hersey, Wen-Jen Hwu, Omid Hamid, Caroline Robert, Tara C. Gangadhar, Antoni Ribas, Scott J. Diede, F. Stephen Hodi, Hassane M. Zarour, Roxana S. Dronca, Jedd D. Wolchok

المصدر: Journal of Clinical Oncology. 36:1668-1674

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Skin Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, law.invention, Cohort Studies, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Carcinoma, Humans, Neoplasm Metastasis, Melanoma, Aged, business.industry, Middle Aged, medicine.disease, Discontinuation, Clinical trial, 030104 developmental biology, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Monoclonal, Female, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc80c548aef4a43c6afca48a89a7e9fTest
https://doi.org/10.1200/jco.2017.75.6270Test

المؤلفون: Jean-Jacques Grob, Michal Lotem, Christian U. Blank, Catriona M. McNeil, Jacob Schachter, James Larkin, Adil Daud, Omid Hamid, Laurent Mortier, Ana Arance, Matteo S. Carlino, Bart Neyns, Paul Lorigan, Shu Chih Su, Antoni Ribas, Teresa M. Petrella, Georgina V. Long, Clemens Krepler, Caroline Robert, Nageatte Ibrahim

المساهمون: Clinical sciences, Medical Oncology, Laboratory for Medical and Molecular Oncology, Laboratory of Molecullar and Cellular Therapy

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, advanced melanoma, medicine.medical_specialty, Phases of clinical research, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Progression-free survival, ipilimumab, KEYNOTE-006, Melanoma, Aged, Neoplasm Staging, Proportional Hazards Models, Medicine(all), business.industry, Proportional hazards model, Hazard ratio, Middle Aged, Progression-Free Survival, Clinical trial, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, pembrolizumab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b24205b257822ddbf30cee39b4dc1f9Test
https://biblio.vub.ac.be/vubirTest/(e2696151-46a7-4118-9960-b3e5b06df058).html

المؤلفون: Ana Arance, Thomas F. Gajewski, Christian Caglevic, Mark M. Jones, Janet Maleski, Caroline Robert, Lev V. Demidov, Omid Hamid, Tae Min Kim, Scott J. Diede, Stéphane Dalle, Tara C. Mitchell, Matteo S. Carlino, Reinhard Dummer, Georgina V. Long, James R. Anderson, Jean-Jacques Grob, James Larkin

المساهمون: University of Zurich, Long, Georgina V

المصدر: Ann Transl Med

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, medicine.medical_specialty, Population, 610 Medicine & health, Pembrolizumab, Placebo, Antibodies, Monoclonal, Humanized, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, medicine, Humans, Progression-free survival, education, Melanoma, Aged, education.field_of_study, Sulfonamides, business.industry, Hazard ratio, 10177 Dermatology Clinic, Middle Aged, Interim analysis, Progression-Free Survival, Clinical trial, Editorial Commentary, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, 2730 Oncology, business

وصف الملف: 805_Long_GV._et_al._Epacadostat_plus_pembrolizumab_versus_placebo_plus_pembrolizumab_in_patients_with_unresectable_or_metastatic_melanoma_etc._Lancet_Oncol_2019.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994d50fe36f67262fd59a66df91baccbTest
https://www.zora.uzh.ch/id/eprint/172887Test/

المؤلفون: Anna C. Pavlick, Michael T. Tetzlaff, S-C. Su, R. Singh, Janis M. Taube, Richard A. Scolyer, Georgina V. Long, Caroline Robert, R. Dummer, H.A-H. Tawbi, Scott J. Diede, Antoni Ribas, Michael A. Postow

المصدر: Annals of Oncology. 32:S903

مصطلحات موضوعية: Oncology, business.industry, Melanoma, Cancer research, Medicine, Hematology, Pembrolizumab, business, medicine.disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::45fdd3e75cbe85236f3c61c615e872b7Test
https://doi.org/10.1016/j.annonc.2021.08.1477Test

المؤلفون: Olivier Dereure, C. Jarvis, Nicolas Meyer, F. Brunet-Possenti, Laurent Mortier, J.-J. Grob, Florent Grange, C. Dutriaux, E. Scherrer, M.-T. Leccia, E-M. Neidhardt, Caroline Robert, A. Spampinato, F. Aubin, L. Verdoni, Philippe Saiag, Nora Kramkimel, Laurent Machet, A-B. Duval-Modeste, L. Benmahammed-Bellagha

المصدر: Annals of Oncology. 32:S895

مصطلحات موضوعية: medicine.medical_specialty, Oncology, Horizon (archaeology), business.industry, General surgery, medicine, Hematology, Pembrolizumab, business, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ac3d0b71c3636ecb3af6e8951229878eTest
https://doi.org/10.1016/j.annonc.2021.08.1465Test

المؤلفون: Jonathan Cebon, Neil Steven, Mark R. Middleton, Darcy A. Hille, Erika Richtig, Céleste Lebbé, Nageatte Ibrahim, Euan Walpole, Caroline Robert, Giuseppe Masucci, Wei Zhou, Wilson H. Miller, Teresa M. Petrella

المصدر: European Journal of Cancer. 86:115-124

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Time Factors, Longitudinal data, Health Status, Population, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Quality of life, Internal medicine, medicine, Humans, In patient, Patient Reported Outcome Measures, 030212 general & internal medicine, education, Melanoma, Advanced melanoma, education.field_of_study, business.industry, Eortc qlq c30, Middle Aged, humanities, Surgery, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Quality of Life, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e890ea1bf10f65d9c5dbe680fbd78ba4Test
https://doi.org/10.1016/j.ejca.2017.08.032Test

المؤلفون: Caroline Robert, Pablo Cerezuela-Fuentes, Stéphane Dalle, Brigitte Dréno, Miguel Fernández de Sanmamed Gutiérrez, Luis Merino, Vanesa Pons Sanz, Maria Gonzalez Cao, Alfonso Berrocal, Marisol Quintero, Juan Francisco Rodriguez-Moreno, Javier Sánchez-López, Ana Arance, Juana Oramas, Pilar Lopez Criado, Julie Charles, Sofía España, Philippe Saiag, María Rojas, Eduardo Castanon, Helena Escuin-Ordinas, Henri Montaudié, Sonia Maciá, Ivan Marquez-Rodas, Caroline Dutriaux

المصدر: Cancer Research. 81:CT233-CT233

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Melanoma, Mucosal melanoma, Cancer, Pembrolizumab, medicine.disease, Internal medicine, medicine, Immunogenic cell death, Nivolumab, business, CD8, Progressive disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9e9eb08af652def9008252a5262ad131Test
https://doi.org/10.1158/1538-7445.am2021-ct233Test

المؤلفون: Andrey Meshcheryakov, Alexander M.M. Eggermont, Christian U. Blank, Michal Kicinski, Ragini R. Kudchadkar, Victoria Atkinson, Nageatte Ibrahim, Mario Mandalà, Pablo L. Ortiz-Romero, Inge Marie Svane, Georgina V. Long, Catherine Barrow, Anna Maria Di Giacomo, Stefan Suciu, Alexander C.J. van Akkooi, Clemens Krepler, Rosalie Stephens, Caroline Robert, Shahneen Sandhu, Sandrine Marreaud

المصدر: Journal of Clinical Oncology. 39:9500-9500

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, Placebo, Complete resection, Stage III cutaneous melanoma, Gastroenterology, Oncology, Internal medicine, Medicine, Stage III melanoma, Lymph, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b78b72df461dc1b73ea9d7b00a0cabf3Test
https://doi.org/10.1200/jco.2021.39.15_suppl.9500Test